Human papillomavirus type 18 L1 protein adsorbed
Human papillomavirus type 18 L1 protein adsorbed · HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN .32 mg/mL · Liquid · Boehringer Ingelheim RCV GmbH & Co KG
NDC 68594-0012-99 · 45000 mL in 1 BOTTLE, GLASS · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Human papillomavirus type 18 L1 protein adsorbed (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Boehringer Ingelheim RCV GmbH & Co KG | HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN .32 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Human papillomavirus type 18 L1 protein adsorbed — NDC 68594-0012-99," retrieved September 3, 2026, https://drugdashboards.com/drug/68594001299.
Free to cite with attribution — see how the data is put together.